ATE79032T1 - Nifedipine enthaltende zusammensetzungen und verfahren zu ihrer herstellung. - Google Patents

Nifedipine enthaltende zusammensetzungen und verfahren zu ihrer herstellung.

Info

Publication number
ATE79032T1
ATE79032T1 AT90301005T AT90301005T ATE79032T1 AT E79032 T1 ATE79032 T1 AT E79032T1 AT 90301005 T AT90301005 T AT 90301005T AT 90301005 T AT90301005 T AT 90301005T AT E79032 T1 ATE79032 T1 AT E79032T1
Authority
AT
Austria
Prior art keywords
nifedipine
polyvinylpyrrolidone
amount
preparation
compositions containing
Prior art date
Application number
AT90301005T
Other languages
German (de)
English (en)
Inventor
Alan Rhodes
Original Assignee
Ethical Pharma Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ethical Pharma Ltd filed Critical Ethical Pharma Ltd
Application granted granted Critical
Publication of ATE79032T1 publication Critical patent/ATE79032T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Hydrogenated Pyridines (AREA)
AT90301005T 1989-02-14 1990-01-31 Nifedipine enthaltende zusammensetzungen und verfahren zu ihrer herstellung. ATE79032T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB898903328A GB8903328D0 (en) 1989-02-14 1989-02-14 Nifedipine-containing pharmaceutical compositions and process for the preparation thereof

Publications (1)

Publication Number Publication Date
ATE79032T1 true ATE79032T1 (de) 1992-08-15

Family

ID=10651674

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90301005T ATE79032T1 (de) 1989-02-14 1990-01-31 Nifedipine enthaltende zusammensetzungen und verfahren zu ihrer herstellung.

Country Status (17)

Country Link
US (1) US5145683A (enExample)
EP (1) EP0385582B1 (enExample)
JP (1) JPH07112974B2 (enExample)
AT (1) ATE79032T1 (enExample)
AU (1) AU626130B2 (enExample)
CA (1) CA2008972C (enExample)
DE (1) DE69000240T2 (enExample)
DK (1) DK0385582T3 (enExample)
ES (1) ES2052168T3 (enExample)
FI (1) FI95347C (enExample)
GB (1) GB8903328D0 (enExample)
GR (1) GR3005477T3 (enExample)
IE (1) IE64682B1 (enExample)
NO (1) NO175925C (enExample)
NZ (1) NZ232287A (enExample)
PH (1) PH26850A (enExample)
ZA (1) ZA90904B (enExample)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5624683A (en) * 1986-08-06 1997-04-29 Eisai Co., Ltd. Sustained-release multi-granule tablet
GB9200607D0 (en) * 1992-01-13 1992-03-11 Ethical Pharma Ltd Pharmaceutical compositions containing nifedipine and process for the preparation thereof
US6726930B1 (en) * 1993-09-09 2004-04-27 Penwest Pharmaceuticals Co. Sustained release heterodisperse hydrogel systems for insoluble drugs
US5773025A (en) 1993-09-09 1998-06-30 Edward Mendell Co., Inc. Sustained release heterodisperse hydrogel systems--amorphous drugs
US5455046A (en) * 1993-09-09 1995-10-03 Edward Mendell Co., Inc. Sustained release heterodisperse hydrogel systems for insoluble drugs
US5662933A (en) * 1993-09-09 1997-09-02 Edward Mendell Co., Inc. Controlled release formulation (albuterol)
DE59410044D1 (de) * 1994-12-29 2002-03-21 Shire Deutschland Gmbh & Co Kg Pharmazeutische zubereitungen, enthaltend nifedipin und verfahren zu ihrer herstellung
US5871776A (en) * 1995-01-31 1999-02-16 Mehta; Atul M. Controlled-release nifedipine
CN1049114C (zh) * 1995-12-07 2000-02-09 上海华联制药公司 一种制备缓释药物制剂的方法
JP3148256B2 (ja) 1996-07-08 2001-03-19 エドワード メンデル カンパニー.,インコーポレーテッド 高用量難溶性薬物用持続放出マトリックス
EP0852141A1 (en) 1996-08-16 1998-07-08 J.B. Chemicals & Pharmaceuticals Ltd. Nifedipine containing pharmaceutical extended release composition and a process for the preparation thereof
IT1284604B1 (it) * 1996-09-27 1998-05-21 Roberto Valducci Composizioni farmaceutiche a rilascio controllato per somministrazione orale contenenti nifedipina come sostanza attiva
US5837379A (en) * 1997-01-31 1998-11-17 Andrx Pharmaceuticals, Inc. Once daily pharmaceutical tablet having a unitary core
US5922352A (en) * 1997-01-31 1999-07-13 Andrx Pharmaceuticals, Inc. Once daily calcium channel blocker tablet having a delayed release core
IN186245B (enExample) 1997-09-19 2001-07-14 Ranbaxy Lab Ltd
US6056977A (en) 1997-10-15 2000-05-02 Edward Mendell Co., Inc. Once-a-day controlled release sulfonylurea formulation
US6485748B1 (en) 1997-12-12 2002-11-26 Andrx Pharmaceuticals, Inc. Once daily pharmaceutical tablet having a unitary core
US6168806B1 (en) 1999-03-05 2001-01-02 Fang-Yu Lee Orally administrable nifedipine pellet and process for the preparation thereof
US20040115134A1 (en) * 1999-06-22 2004-06-17 Elan Pharma International Ltd. Novel nifedipine compositions
JP4627825B2 (ja) * 1999-09-27 2011-02-09 三生医薬株式会社 被包粒状物質及びその製造方法
HK1042427A1 (zh) * 1999-09-30 2002-08-16 Penwest Pharmaceuticals Co. 用於高溶度药物的持续释放基质方法
RU2188635C2 (ru) * 1999-10-12 2002-09-10 Открытое акционерное общество "Щелковский витаминный завод" Композиционный состав лекарственного средства - блокатора медленных кальциевых каналов
US7364752B1 (en) 1999-11-12 2008-04-29 Abbott Laboratories Solid dispersion pharamaceutical formulations
EP1175205B1 (en) * 1999-11-12 2006-06-14 Abbott Laboratories Solid dispersion comprising ritonavir, fenofibrate or griseofulvin
DE10026698A1 (de) * 2000-05-30 2001-12-06 Basf Ag Selbstemulgierende Wirkstoffformulierung und Verwendung dieser Formulierung
KR20030034171A (ko) * 2001-07-06 2003-05-01 엔도 파마슈티걸즈, 인크. 옥시모르폰 제어 방출 제형
US8377952B2 (en) 2003-08-28 2013-02-19 Abbott Laboratories Solid pharmaceutical dosage formulation
US8025899B2 (en) 2003-08-28 2011-09-27 Abbott Laboratories Solid pharmaceutical dosage form
WO2008067164A2 (en) * 2006-11-15 2008-06-05 Abbott Laboratories Solid pharmaceutical dosage formulations
GB2460915B (en) * 2008-06-16 2011-05-25 Biovascular Inc Controlled release compositions of agents that reduce circulating levels of platelets and methods therefor
RU2629843C1 (ru) * 2016-05-24 2017-09-04 федеральное государственное автономное образовательное учреждение высшего образования Первый Московский государственный медицинский университет имени И.М. Сеченова Министерства здравоохранения Российской Федерации (Сеченовский университет) Способ получения мази нифедипина (варианты)
CN109172534B (zh) * 2018-10-23 2020-08-07 迪沙药业集团有限公司 一种硝苯地平缓释片剂组合物

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1579818A (en) * 1977-06-07 1980-11-26 Yamanouchi Pharma Co Ltd Nifedipine-containing solid preparation composition
US4285665A (en) * 1978-05-08 1981-08-25 Johnson, Matthey & Co., Limited Engines
DE3033919A1 (de) * 1980-09-09 1982-04-22 Bayer Ag, 5090 Leverkusen Feste arzneizubereitungen enthaltend nifedipin und verfahren zu ihrer herstellung
JPS5846019A (ja) * 1981-09-14 1983-03-17 Kanebo Ltd 持続性ニフエジピン製剤
DE3318649A1 (de) * 1983-05-21 1984-11-22 Bayer Ag, 5090 Leverkusen Zweiphasenformulierung
FR2556964A1 (fr) * 1983-12-23 1985-06-28 Ile De France Nouvelles formes galeniques du sulpiride utilisables par voie orale
DE3424553A1 (de) * 1984-07-04 1986-01-09 Bayer Ag, 5090 Leverkusen Feste arzneizubereitungen mit dihydropyridinen und verfahren zu ihrer herstellung
IT1178511B (it) * 1984-09-14 1987-09-09 Pharmatec Spa Procedimento per la preparazione di una forma solida per uso orale a base di nifedipina con rilascio
IT1187751B (it) * 1985-10-15 1987-12-23 Eurand Spa Procedimento per la preparazione di formulazioni solidi di nifedipina ad elevata biodisponibilita' e ad effetto prolungato e formulazioni cosi' ottenute
SE457326B (sv) * 1986-02-14 1988-12-19 Lejus Medical Ab Foerfarande foer framstaellning av en snabbt soenderfallande kaerna innehaallande bl a mikrokristallin cellulosa

Also Published As

Publication number Publication date
CA2008972C (en) 1996-09-03
NO175925B (no) 1994-09-26
AU626130B2 (en) 1992-07-23
EP0385582A1 (en) 1990-09-05
DE69000240D1 (de) 1992-09-10
NZ232287A (en) 1992-01-29
GB8903328D0 (en) 1989-04-05
IE900286L (en) 1990-08-14
NO175925C (no) 1995-01-04
DE69000240T2 (de) 1993-02-11
FI95347B (fi) 1995-10-13
FI95347C (fi) 1996-01-25
NO900370L (no) 1990-08-15
US5145683A (en) 1992-09-08
EP0385582B1 (en) 1992-08-05
PH26850A (en) 1992-11-05
JPH07112974B2 (ja) 1995-12-06
DK0385582T3 (da) 1992-09-14
FI900633A0 (fi) 1990-02-08
NO900370D0 (no) 1990-01-26
GR3005477T3 (enExample) 1993-05-24
CA2008972A1 (en) 1990-08-14
IE64682B1 (en) 1995-08-23
JPH02235815A (ja) 1990-09-18
AU4893790A (en) 1990-08-23
ES2052168T3 (es) 1994-07-01
ZA90904B (en) 1991-06-26

Similar Documents

Publication Publication Date Title
DE69000240D1 (de) Nifedipine enthaltende zusammensetzungen und verfahren zu ihrer herstellung.
CA2387705A1 (en) Stable pharmaceutical composition for oral use
NZ221962A (en) Oral pharmaceutical compositions comprising a mixture of ibuprofen and aluminium hydroxide and process for their preparation
HU901380D0 (en) Controlling released coat for long-acting compositions
Bertacchini et al. Solubility and fluoride release in ionomers and compomers.
IL111400A0 (en) Pharmaceutical compositions containing metroprolol and methods for the preparation thereof
YU35893A (sh) Formulacije oksidona sa kontrolisanim otpuštanjem i njihova upotreba
EE05533B1 (et) Farmatseutiline kompositsioon ja preparaat, mis sisaldab mikroniseeritud drospirenooni ja ”strogeeni ning nende kasutamine
KR100257803B1 (en) Stable hydrated cephalosporin dry powder for oral suspension formulation
ATE420630T1 (de) Pulverzubereitungen und verfahren zu ihrer herstellung
PT85591A (en) Process for the preparation of multiple unit dosage pharmaceutical compositions comprising as a pharmaceutilly active compound l-dopa
EP0068450A3 (en) Pharmaceutical forms for oral administration
EP0602860A1 (en) Nail polish remover with gelatin
DE3585107D1 (de) Feste arzneizubereitungen mit dihydropyridin und verfahren zu ihrer herstellung.
AU2004083A (en) Compressed hydroxybutryic acid polymer retarded release vehicle
DK0519950T3 (da) Præparat
DE1292303T1 (de) Eine stabile pharmazeutische formulierung die torsemid modifikation ii enthält
DE68900903D1 (de) Diltiazem-mikrokugeln, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen mit gesteuerter abgabe.
FR2477015B1 (enExample)
DE69108976D1 (de) Neue Polycarbophil enthaltende pharmazeutische Zusammensetzungen und Verfahren zu deren Herstellung.
DE69107274D1 (de) Phenoxyessigsäure-Derivate, Verfahren zu ihrer Herstellung, und pharmazeutische Zusammensetzungen die sie enthalten.
BG51522A1 (en) Compound for mentistry wax
YU20050409A (sh) Kompozicije oksikodona sa kontrolisanim oslobađanjem

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee